Expertise in
8
conditions

Dr. Joseph R. Kelley

Oncology
AdventHealth Medical Group Radiation Oncology At Marion
63 S Medical Ct, 
Marion, NC 
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
AdventHealth Medical Group Radiation Oncology At Marion
63 S Medical Ct, 
Marion, NC 

Overview

Joseph Kelley is an Oncologist practicing medicine in Marion, North Carolina.

Dr. Kelley is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Angiosarcoma of the Scalp.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Kelley is currently accepting new patients.

Specialties

Oncology

Licenses

Radiology in NC

Hospital Affiliations

Harris Regional Hospital
Memorial Mission Hospital And Asheville Surgery Ce
Scotland Memorial Hospital
Johnson City Medical Center
Haywood Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Prominence Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

AdventHealth Medical Group Radiation Oncology at Marion
63 S Medical Ct, Marion, NC 28752
Other Locations
AdventHealth Medical Group Radiation Oncology at Asheville
20 Medical Park Dr, Asheville, NC 28803

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Enrollment Status: Active_not_recruiting
Publish Date: May 27, 2026
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
Phase 3, Open-Label, 4-Cohort Study of Nogapendekin Alfa Inbakicept in Combination With Current Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 3, Open-Label, 4-Cohort Study of Nogapendekin Alfa Inbakicept in Combination With Current Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: May 26, 2026
Intervention Type: Drug
Study Drugs: N-803+Pembrolizumab, N-803+Carboplatin+Nab-paclitaxel+Pembrolizumab, N-803+Cisplatin or Carboplatin+Pembrolizumab+Pemetrexed, Pembrolizumab, Carboplatin+Nab-paclitaxel or Paclitaxel+Pembrolizumab, Cisplatin or Carboplatin+Pembrolizumab+Pemetrexed
Study Phase: Phase 3
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

2 Total Publications

Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN).
Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN).
Journal: EClinicalMedicine
Published: December 29, 2024
Similar Doctors
Expertise in
12
conditions
Dr. Kim E. Nichols
Hematology | Oncology
Expertise in
12
conditions
Dr. Kim E. Nichols
Hematology | Oncology
Referral may be required
Before you request

ETSU Pediatrics- St. Jude's Clinic

400 N State Of Franklin Rd, Fl 1, 
Johnson City, TN 
 (48.7 miles away)
423-431-3950
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Kim Nichols is a Hematologist and an Oncologist practicing medicine in Johnson City, Tennessee. Dr. Nichols is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Transplant. Dr. Nichols is board certified in American Board Of Pediatrics. Dr. Nichols is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Gynecologic Oncology (Spartanburg)

101 East Wood Street, Floor 3, 
Spartanburg, SC 
 (48.5 miles away)
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carlton Schwab is an Oncologist practicing medicine in Spartanburg, South Carolina. He has been practicing medicine for over 17 years. Dr. Schwab is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ovarian Carcinosarcoma, Endometrial Cancer, Ovarian Cancer, Bladder Reconstruction, and Hernia Surgery. Dr. Schwab is board certified in American Board Of Obstetrics & Gynecology, (Obstetrics & Gynecology), and (Obstetrics & Gynecology, Gynecologic Oncology). Dr. Schwab is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Hope Women's Cancer Center

100 Ridgefield Ct, 
Asheville, NC 
 (33.7 miles away)
828-670-8403
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Vanderkwaak is an Oncologist practicing medicine in Asheville, North Carolina. Dr. Vanderkwaak is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Splenectomy. Dr. Vanderkwaak is currently accepting new patients.

Frequently Asked Questions about Dr. Joseph R. Kelley

How do I make an appointment with Dr. Joseph R. Kelley?

You can book an appointment with Dr. Joseph R. Kelley by calling their office at 828-659-2130. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joseph R. Kelley a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph R. Kelley is classified as an Advanced expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joseph R. Kelley specialize in?

While Dr. Joseph R. Kelley is a Oncology, they have specific expertise in Paget Disease of the Breast, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Joseph R. Kelley participate in research or clinical trials?

Yes. Dr. Joseph R. Kelley has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Joseph R. Kelley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joseph R. Kelley accept my insurance?

Dr. Joseph R. Kelley accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 828-659-2130 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kelley's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 62 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile